Christopher Downs is CFO at CNS Pharmaceuticals, Inc. (CNSP). They have made 7 open-market trades across 2 companies since 2017, most recently 2024-02-01.
CIK 0001705978
7 open-market purchases totalling $379K since 2017, never a sale. Across 7 scored buys the stock is down 17.2% at ninety days, and 18.0 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 14% | 43% |
| Avg Move | -7.9% | -11.8% | -17.2% |
| Alpha | -7.4% | -11.4% | -18.0% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CNSP | BUY | 2024-02-01 | 2024-02-06 | $0.30 | $20K | -5.3% | +45.9% | -32.8% |
| CNSP | BUY | 2023-08-22 | 2023-08-23 | $1.27 | $34K | -6.0% | -30.4% | +24.4% |
| CNSP | BUY | 2023-04-17 | 2023-04-18 | $3.20 | $10K | -13.7% | -22.9% | +22.3% |
| CNSP | BUY | 2021-12-06 | 2021-12-07 | $0.94 | $5K | -8.2% | -22.4% | -72.9% |
| CNSP | BUY | 2021-11-19 | 2021-11-22 | $1.15 | $5K | -10.4% | -19.8% | -69.4% |
| CNSP | BUY | 2020-08-24 | 2020-08-25 | $2.04 | $290K | -12.2% | -28.2% | -3.3% |
| INFU | BUY | 2017-08-14 | 2017-08-16 | $1.90 | $15K | +0.3% | -5.1% | +11.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.